Background and Objectives. It has been previously demonstrated that dendritic cells (DCs) are characterized by an immature stage with high antigen internalization capacity, followed by a mature stage with predominantly immunostimulatory ability. The shift from the immature to the mature state can be induced in vitro by the addition of tumor necrosis factor-α (TNFα). The aim of our study was to investigate the maturation steps of DCs obtained from CD34+ cells from peripheral blood stem cells (PBSC) and bone marrow (BM). Design and Methods. DCs were generated in vitro from PBSC and BM CD34+ selected cells. The endocytic activity of the cells was measured by means of dextran-FITC uptake and alloreactivity evaluated with mixed leukocyte reactions. Immunophenotypic analysis was performed by flow cytometry. Results. We observed that DCs from PBSC, in contrast to the BM derived DCs, were never able to take up soluble antigens. Mixed leukocyte reaction (MLR) performed both on PBSC and BM CD34+ derived DCs showed an allo-stimulatory activity comparable to normal controls at day 10, but significantly higher at day 14 after the addition of TNFα. Immunophenotypic analysis showed typical dendritic markers in all the samples and, after treatment with TNFα, enhanced expression of co-stimulatory molecules. Interpretation and Conclusions. Our data seem to indicate that, in our culture conditions. BM-derived DCs could be efficiently used for pulsing with specific peptides, while PBSC-derived DC, being functionally mature, should be more suitable for gene therapy. (C) 2000, Ferrata Storti Foundation.

Functional differences between dendritic cells derived from CD34+ bone marrow and peripheral blood stem cells / F. Servida, D. Soligo, G. Lambertenghi Deliliers. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 85:4(2000 Apr), pp. 352-355.

Functional differences between dendritic cells derived from CD34+ bone marrow and peripheral blood stem cells

D. Soligo
Secondo
;
G. Lambertenghi Deliliers
Ultimo
2000

Abstract

Background and Objectives. It has been previously demonstrated that dendritic cells (DCs) are characterized by an immature stage with high antigen internalization capacity, followed by a mature stage with predominantly immunostimulatory ability. The shift from the immature to the mature state can be induced in vitro by the addition of tumor necrosis factor-α (TNFα). The aim of our study was to investigate the maturation steps of DCs obtained from CD34+ cells from peripheral blood stem cells (PBSC) and bone marrow (BM). Design and Methods. DCs were generated in vitro from PBSC and BM CD34+ selected cells. The endocytic activity of the cells was measured by means of dextran-FITC uptake and alloreactivity evaluated with mixed leukocyte reactions. Immunophenotypic analysis was performed by flow cytometry. Results. We observed that DCs from PBSC, in contrast to the BM derived DCs, were never able to take up soluble antigens. Mixed leukocyte reaction (MLR) performed both on PBSC and BM CD34+ derived DCs showed an allo-stimulatory activity comparable to normal controls at day 10, but significantly higher at day 14 after the addition of TNFα. Immunophenotypic analysis showed typical dendritic markers in all the samples and, after treatment with TNFα, enhanced expression of co-stimulatory molecules. Interpretation and Conclusions. Our data seem to indicate that, in our culture conditions. BM-derived DCs could be efficiently used for pulsing with specific peptides, while PBSC-derived DC, being functionally mature, should be more suitable for gene therapy. (C) 2000, Ferrata Storti Foundation.
Antigen uptake; CD34+ cells; Dendritic cells; TFNα
Settore MED/09 - Medicina Interna
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/47166
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? ND
social impact